http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20060082656-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd7c27b9ec61781656e6f039702fd568
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-76
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-70
filingDate 2005-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6aa48afe0fe205ba239bc4d3e237f5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4e7c460a9ecb41256e397a6610b4da4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ec1dfc9ebd25da4ec9cf2187493eb2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bd04d5619448f27700183d1e5eb69bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36e13919481b266538e12ba89f31c4f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eec90cfe6c98d15b0df154b5f968533c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fada36aaa19a428337fe698fa84df98
publicationDate 2006-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20060082656-A
titleOfInvention (Cromen-6-carbonyl) guanidine derivative, preparation method thereof and agent for preventing and treating ischemic heart disease comprising the same
abstract The present invention relates to a (chromen-6-carbonyl) guanidine derivative, a preparation method thereof, and an agent for preventing and treating ischemic heart disease including the same. The (chromen-6-carbonyl) guanidine derivatives of the present invention enhance cardiac function recovery against ischemia / reperfusion injury and reduce myocardial infarction rate through a potent inhibitory action on sodium / hydrogen exchange pathway NHE-1. By protecting the cells, it can be used as an agent for the prevention and treatment of ischemic heart diseases such as myocardial infarction, heart failure, angina pectoris, and cardioprotection during reperfusion therapy such as coronary artery bypass surgery, coronary percutaneous plastic surgery, or drug therapy using thrombolytics. Can be used zero.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100720045-B1
priorityDate 2005-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467189713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467189714

Total number of triples: 24.